BioSig’s PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias
October 12, 2021 09:15 ET
|
BioSig Technologies, Inc.
Westport, CT, Oct. 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiovascular Electrophysiology
October 04, 2021 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Oct. 04, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal...
BioSig Selects Plexus Corp. as its Manufacturing Partner
September 28, 2021 09:15 ET
|
BioSig Technologies, Inc.
Westport, CT, Sept. 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
September 21, 2021 10:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Sept. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Global Organ Care System for Heart Market Anticipated to Garner a Revenue of $44.02 Million at a CAGR of 19.4% during the Forecast Period, 2019-2026 COVID-19 Disaster - Exclusive Report by Research Dive
September 21, 2021 09:30 ET
|
Research Dive
New York, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global organ care system for heart market is forecasted to reach $44.02 million by the end of...
BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System
September 13, 2021 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Global Organ Care System for Heart Market Expected to Garner Revenue of $37.2 Million by 2026 at a CAGR of 16.5% from 2019-2026 - Exclusive Report [90-Pages] by Research Dive
September 08, 2021 09:00 ET
|
Research Dive
New York, USA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- The latest report by Research Dive states that the global organ care system for heart market is predicted to witness a rise in revenue from $11.0...
BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium
August 31, 2021 10:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 31, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium
August 19, 2021 11:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention
July 20, 2021 14:00 ET
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...